When most people think of Parkinson’s disease, they picture the characteristic tremor—that involuntary shaking that has become almost synonymous with the condition. But the reality is far more complex than just one visible symptom. Let’s dig into what’s actually happening in the brain, how doctors figure out what’s going on, and what living with this condition really looks like.
What Causes Parkinson’s Disease?
Here’s where things get frustrating for researchers: despite decades of study, scientists still don’t know exactly what causes the nerve cells in the brain to die. I’m going to apologize in advance because I’m going to be using a lot of “doctor talk”—no way around it.
What we do know is that nerve cells (neurons) in the substantia nigra portion of the basal ganglia—an area of the brain controlling movement—become impaired or die, and these neurons normally produce dopamine, an important brain chemical. When these cells stop working properly, dopamine levels drop, and that’s when movement problems begin showing up.
But dopamine isn’t the whole story. People with Parkinson’s also lose nerve endings that produce norepinephrine, the main chemical messenger of the sympathetic nervous system, which helps explain why the disease affects so much more than just movement—things like blood pressure, digestion, and energy levels all take a hit.
Most Parkinson’s cases are idiopathic, meaning the cause is unknown, though contributing factors have been identified. Current thinking suggests a complicated mix of genetic and environmental factors. About 5% to 10% of cases begin before age 50, and these early-onset forms are often, though not always, inherited.
Some risk factors have emerged from research: age is the most significant, with about 1% of those over 65 and around 4.3% of those over 85 affected. Traumatic brain injury significantly increases risk, especially if recent, and repeated head injuries from contact sports can cause what’s called post-traumatic parkinsonism. Muhammad Ali is a classic example of this.
Exposure to pesticides and industrial chemicals has also been identified as a risk factor. Interestingly, large epidemiologic studies consistently show that people who smoke have a lower risk of being diagnosed with Parkinson’s disease than never‑smokers, although smoking is still strongly discouraged because of its many harmful health risks. Large cohort studies in the U.S. and Europe generally find no direct association between alcohol consumption and Parkinson’s disease. A few observational studies show that moderate drinkers have slightly lower Parkinson’s rates. However, researchers believe this may be due to reverse causation (people in early or undiagnosed stages often reduce drinking because of GI or mood changes) and lifestyle confounders (moderate drinkers may differ in socioeconomic status, diet, or activity level). So, the “protective” effect is considered speculative, not causal.
The Symptoms: More Than Just Shaking
The hallmark movement symptoms—what doctors call “motor symptoms”—are what usually bring people to the doctor. Slowed movements, called bradykinesia, is required for a Parkinson’s diagnosis. People describe it as muscle weakness, though it’s really about control, not strength. The classic tremor, stiffness, and balance problems round out the main movement issues. Patients frequently show reduced arm swing, shuffling gait, difficulty initiating movement or turning, masked facial expression, decreased blinking, and soft or monotone speech.
But here’s what often surprises people: many individuals later diagnosed with Parkinson’s notice that prior to experiencing stiffness and tremor, they had sleep problems, constipation, loss of smell, and restless legs. These “prodromal symptoms” can show up years before the movement problems become obvious. Other early signs include mood disorders like anxiety and depression.
The cognitive side deserves attention too. Some people experience changes in cognitive function, including problems with memory, attention, and the ability to plan and accomplish tasks, though hard to pin down due to concurrence with age related memory problems, 20% at the time of diagnosis is a commonly cited number. More contested is how many develop Parkinson’s dementia, with estimates ranging from 20% all the way to 85%.
How Doctors Make the Diagnosis
Here’s something that might surprise you: there are currently no blood or laboratory tests to diagnose non-genetic cases of Parkinson’s. The standard diagnosis is clinical, meaning there’s no test that can give a conclusive result—certain physical symptoms need to be present.
Doctors typically diagnose Parkinson’s by taking a detailed medical history and performing a neurological examination. If symptoms improve after starting medication, that’s another indicator that the person has Parkinson’s.
There are some imaging tools available. The FDA approved an imaging scan called the DaTscan in 2011, which allows doctors to see detailed pictures of the brain’s dopamine system using a radioactive drug and SPECT scanner. But this scan can’t definitively diagnose Parkinson’s though it helps rule out conditions that mimic it. A hallmark of Parkinson’s is the buildup of misfolded alpha-synuclein proteins (Lewy bodies) inside neurons. Whether this is a cause, an effect, or both is still under study—this part of the science remains somewhat speculative.
Recently, researchers developed something more promising: the alpha-synuclein seeding amplification assay can detect abnormal alpha-synuclein in spinal fluid and may detect Parkinson’s in people who haven’t been diagnosed yet. The catch? It requires a spinal tap and isn’t widely available, though scientists are working on blood and saliva tests.
The early diagnostic challenge is real. Many disorders can cause similar symptoms, and people with Parkinson’s-like symptoms from other causes are sometimes said to have parkinsonism, which includes conditions like multiple system atrophy and Lewy body dementia that require different treatments.
What to Expect: The Prognosis
Let’s address the big question: how does Parkinson’s affect life expectancy? The news here is better than you might think. The average life expectancy of a person with Parkinson’s is generally the same as for someone without the disease.
More specifically, average life expectancy has increased by about 55% since 1967, rising to more than 14.5 years from diagnosis. Modern treatments have made a huge difference. Research indicates that those with Parkinson’s and normal cognitive function appear to have a largely normal life expectancy.
That said, timing matters. Research from 2020 suggests that people who receive a diagnosis before age 70 usually experience a greater reduction in life expectancy, and males with Parkinson’s may have a greater reduction in life expectancy than females.
The disease is progressive, meaning it gets worse over time, but symptoms and progression vary from person to person, and neither you nor your doctor can predict which symptoms you’ll get, when, or how severe they’ll be. The tremor-dominant type usually has a more favorable prognosis than the hypokinetic type.
What actually causes death in advanced Parkinson’s? Advanced symptoms can cause falls, pressure ulcers, swallowing difficulties and general frailty, all of which are linked to death. Aspiration pneumonia—when you inhale food or liquid into the lungs—is the leading cause of death for people with Parkinson’s.
Managing the Disease
Currently, there’s no cure for Parkinson’s, but medications or surgery can improve many of the movement symptoms.
The gold standard medication is levodopa (often combined with carbidopa as Sinemet). Healthcare providers use levodopa cautiously and they commonly combine it with other medications to keep your body from processing it before it enters your brain. This helps avoid side effects like nausea, vomiting, and low blood pressure when standing up. The tricky part? Over time, the way your body uses levodopa changes, and it can lose effectiveness.
Beyond levodopa, doctors use MAO-B inhibitors and dopamine agonists. As the disease progresses, these medications become less effective and may cause involuntary muscle movements. When drugs stop working well, there are surgical options to treat severe motor symptoms.
The main surgical treatment today is called deep brain stimulation (DBS). It is the most important therapeutic advancement since the development of levodopa, and it’s been FDA-approved since the late 1990s A surgeon places thin metal wires called electrodes into one or both sides of the brain, in specific areas that control movement. A second procedure implants an impulse generator battery under the collarbone or in the abdomen. It is similar to a heart pacemaker and about the size of a stopwatch, this device delivers electrical stimulation to those targeted brain areas.
A new treatment that is being used is focused ultrasound. Guided by MRI, high-intensity, inaudible sound waves are emitted into the brain, and where these waves cross, they create high energy that destroys a very specific area connected to tremor. It’s considered non-invasive and the FDA has approved it for Parkinson’s tremor that doesn’t respond to medications.
Don’t underestimate lifestyle interventions either. Physical therapy can improve balance and address muscle stiffness, and regular exercise improves strength, flexibility, and balance. Eating a balanced diet helps—drinking plenty of water and eating enough fiber reduces constipation, while omega-3 fats and magnesium may boost cognition and help with anxiety.
Parkinson’s disease sits at the intersection of aging, genetics, environment, and biology. Diagnosis is clinical, progression is gradual and variable, and treatment has become increasingly sophisticated. While it remains incurable, early diagnosis, personalized medication plans, targeted therapies like DBS, and consistent exercise allow many people to maintain meaningful independence for years.
The key message from specialists? Treatment makes a major difference in keeping symptoms from having worse effects, and adjustments to medications and dosages can hugely impact how Parkinson’s affects your life.